![]() DermBiont DermBiont develops skin microbiome therapeutics platform to treat and prevent skin diseases. | ![]() Nouscom Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
| ![]() Velabs Therapeutics Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies. | |
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date N/A |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Boston, US HQ Emeryville, US | Locations Basel, CH HQ Roma, IT | Locations Heidelberg, DE HQ |
Employees | Employees 215% decrease | Employees 633% increase | Employees N/A |
Funding | |||
Latest funding round | Latest funding round $ 8m (almost 7 years ago) | Latest funding round $ 49m (over 8 years ago) | Latest funding round $ 3.4m (almost 7 years ago) |
Total funding raised | Total funding raised $ 8m | Total funding raised $ 62.6m | Total funding raised $ 3.4m |

Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
View company
Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies.
View company